Emily Ayers, MD

PRIMARY APPOINTMENT:
Assistant Professor, Medicine: Hematology and Oncology

CONTACT:
UVA Division of Hematology/Oncology
PO Box 800716
Charlottesville, VA 22908
Telephone: 434-297-4109
Fax: 434-244-7534

Primary Education
Columbia University College of Physicians and Surgeons

Residency
Perelman School of Medicine at the University of Pennsylvania

Fellowships
Perelman School of Medicine at the University of Pennsylvania

Interest in using real world evidence and real world data to study outcomes among patients with relapsed or refractory b-cell lymphomas and to identify predictors of response to novel agents in this patient population. Additional interest in clinical trials for patients with lymphoma and chronic lymphocytic leukemia.

A phase Ib open-label study to evaluate the safety and anti-cancer activity of loncastuximab terisine in combination with other anti-cancer agents in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

A Phase II trial Evaluating Safety and Efficacy of Epcoritamab with Gemcitabine, Dexamethasone, and Cisplatin (GDP) SalvageChemotherapy in Relapsed Refractory Large B-cell Lymphoma.

A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in combination With R-CHP Versus R-CHOP inParticipants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010)